Lao H. Saal

Domos (Norway) — Norway

Biochemistry, Genetics and Molecular Biology · Life Sciences

41h-index12.1kcitations189works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(60), Breast Cancer Treatment Studies(23), Gene expression and cancer classification(23), PI3K/AKT/mTOR signaling in cancer(22), Cancer Cells and Metastasis(21)

Publications189 total

Real-world utility of Histotype Px colorectal as a prognostic and potentially predictive biomarker.
Journal of Clinical Oncology·2026
52P External validation of Histotype Px® Colorectal for risk stratification in a US patient cohort
ESMO Real World Data and Digital Oncology·2025Open Access
726O Prognostic value of the combined analysis of pathologists and artificial intelligence (CAPAI) in high-risk stage II-III colon cancer treated without chemotherapy: Interim report from a nationwide validation
Annals of Oncology·2025
Introduction to Your Rights and Care Standards: A Guide for People with Type 2 Diabetes
Clinical Diabetes·2025Open Access
Potential of tumor-informed ctDNA as an early predictive indicator for relapse in advanced ovarian cancer.
Journal of Clinical Oncology·2025
Complementary value of a digital pathology biomarker to post-surgery circulating tumor DNA in risk stratification of stage III colon cancer patients receiving adjuvant chemotherapy.
Journal of Clinical Oncology·2025
NeoCircle: Investigating circulating tumor DNA dynamics as a predictor of survival in primary breast cancer.
Journal of Clinical Oncology·2025
Precision Omics Initiative Sweden (PROMISE) will integrate research with healthcare
Nature Medicine·2025· 1 cited
Genomic Characteristics Related to Histology-based Immune Features in Breast Cancer
UNC Libraries·2025Open Access
ctDNA as an Objective Marker for Postoperative Residual Disease in Primary Advanced High-Grade Serous Ovarian Cancer
Cancers·2025· 3 citedOpen Access
Genomic Characteristics Related to Histology-Based Immune Features in Breast Cancer
Modern Pathology·2025· 5 citedOpen Access
Evaluation von tumorspezifischer ctDNA als objektiver Marker für postoperativen Tumorrest beim high-grade serösen Ovarialkarzinom
Geburtshilfe und Frauenheilkunde·2024
Tumor-informed ctDNA as an objective marker for postoperative residual disease in epithelial ovarian cancer.
Journal of Clinical Oncology·2024· 1 cited
Monitoring ctDNA dynamics in early breast cancer using a novel ultra-sensitive tumor-informed structural variant approach combining whole-genome sequencing and multiplex dPCR.
Journal of Clinical Oncology·2024· 1 cited
42P DPD testing from tumor RNAseq in breast cancer: A proof of concept analysis
ESMO Open·2024Open Access
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling
Scientific Reports·2024· 9 citedOpen Access
Digital PCR quantification of ultrahigh ERBB2 copy number identifies poor breast cancer survival after trastuzumab
npj Breast Cancer·2024· 3 citedOpen Access
Preoperative ctDNA Levels Are Associated With Poor Overall Survival in Patients With Ovarian Cancer
Cancer Genomics & Proteomics·2023· 11 citedOpen Access
Mitochondrial heteroplasmic shifts reveal a positive selection of breast cancer
Journal of Translational Medicine·2023· 8 citedOpen Access
805P Tumor-informed ctDNA detection as a predictive marker for postoperative residual disease in epithelial ovarian cancer: A feasibility study
Annals of Oncology·2023· 1 citedOpen Access
page 1 of 10Next →

Frequent Co-authors

Åke Borg(27), Cecilia Hegardt(19), Johan Vallon‐Christersson(19), Lisa Rydén(18), Sofia K. Gruvberger-Saal(17), Martin Malmberg(15), Jari Häkkinen(14), Anna Ehinger(14), Pär‐Ola Bendahl(12), Johan Staaf(12), Niklas Loman(12), Mårten Fernö(10), Christer Larsson(10), Ramon Parsons(9), Markus Ringnér(8), Dorthe Grabau(8), Karolina Holm(7), Hanina Hibshoosh(7), Göran Jönsson(7), Christian Brueffer(7)